Literature DB >> 35288804

Consideration of Fractional Distribution Parameter fd in the Chen and Gross Method for Tissue-to-Plasma Partition Coefficients: Comparison of Several Methods.

Yoo-Seong Jeong1, William J Jusko2.   

Abstract

PURPOSE: The tissue-to-plasma partition coefficient (Kp) describes the extent of tissue distribution in physiologically-based pharmacokinetic (PBPK) models. Constant-rate infusion studies are common for experimental determination of the steady-state Kp,ss, while the tissue-plasma concentration ratio (CT/Cp) in the terminal phase after intravenous doses is often utilized. The Chen and Gross (C&G) method converts a terminal slope CT/Cp to Kp,ss based on assumptions of perfusion-limited distribution in tissue-plasma equilibration. However, considering blood flow (QT) and apparent tissue permeability (fupPSin) in the rate of tissue distribution, this report extends the C&G method by utilizing a fractional distribution parameter (fd).
METHODS: Relevant PBPK equations for non-eliminating and eliminating organs along with lung and liver were derived for the conversion of CT/Cp values to Kp,ss. The relationships were demonstrated in rats with measured CT/Cp and Kp,ss values and the model-dependent fd for 8 compounds with a range of permeability coefficients. Several methods of assessing Kp were compared.
RESULTS: Utilizing fd in an extended C&G method, our estimations of Kp,ss from CT/Cp were improved, particularly for lower permeability compounds. However, four in silico methods for estimating Kp performed poorly across tissues in comparison with measured Kp values. Mathematical relationships between Kp and Kp,ss that are generally applicable for eliminating organs with tissue permeability limitations necessitates inclusion of an extraction ratio (ER) and fd.
CONCLUSION: Since many different types/sources of Kp are present in the literature and used in PBPK models, these perspectives and equations should provide better insights in measuring and interpreting Kp values in PBPK.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Physiologically-based pharmacokinetic (PBPK) modeling; permeability coefficient; tissue distribution rate; tissue-to-plasma partition coefficient

Mesh:

Year:  2022        PMID: 35288804      PMCID: PMC9014445          DOI: 10.1007/s11095-022-03211-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  61 in total

1.  Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.

Authors:  Trudy Rodgers; Malcolm Rowland
Journal:  J Pharm Sci       Date:  2006-06       Impact factor: 3.534

Review 2.  Tissue distribution and pharmacodynamics: a complicated relationship.

Authors:  Jiunn H Lin
Journal:  Curr Drug Metab       Date:  2006-01       Impact factor: 3.731

3.  Physiologically Based Pharmacokinetics of Dexamethasone in Rats.

Authors:  Dawei Song; Le Sun; Debra C DuBois; Richard R Almon; Shengnan Meng; William J Jusko
Journal:  Drug Metab Dispos       Date:  2020-06-29       Impact factor: 3.922

4.  Estimation of the minimum permeability coefficient in rats for perfusion-limited tissue distribution in whole-body physiologically-based pharmacokinetics.

Authors:  Yoo-Seong Jeong; Chang-Soon Yim; Heon-Min Ryu; Chi-Kyoung Noh; Yoo-Kyung Song; Suk-Jae Chung
Journal:  Eur J Pharm Biopharm       Date:  2017-02-12       Impact factor: 5.571

5.  Effect of plasma protein binding on kinetics of capillary uptake and efflux.

Authors:  D J Morgan; J L Huang
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

6.  Effect of altered plasma protein binding on apparent volume of distribution.

Authors:  S Oie; T N Tozer
Journal:  J Pharm Sci       Date:  1979-09       Impact factor: 3.534

7.  Species difference in intestinal absorption mechanism of etoposide and digoxin between cynomolgus monkey and rat.

Authors:  T Nishimura; Y Kato; N Amano; M Ono; Y Kubo; Y Kimura; H Fujita; A Tsuji
Journal:  Pharm Res       Date:  2008-07-15       Impact factor: 4.200

8.  Physiologically based pharmacokinetics of cyclosporine A: extension to tissue distribution kinetics in rats and scale-up to human.

Authors:  R Kawai; D Mathew; C Tanaka; M Rowland
Journal:  J Pharmacol Exp Ther       Date:  1998-11       Impact factor: 4.030

9.  Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.

Authors:  Edward H Kerns; Li Di; Susan Petusky; Michele Farris; Rob Ley; Phil Jupp
Journal:  J Pharm Sci       Date:  2004-06       Impact factor: 3.534

10.  Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases.

Authors:  Yuji Sakurai; Hideyuki Motohashi; Harumasa Ueo; Satohiro Masuda; Hideyuki Saito; Masahiro Okuda; Noriko Mori; Motokazu Matsuura; Toshio Doi; Atsushi Fukatsu; Osamu Ogawa; Ken-ichi Inui
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

View more
  1 in total

1.  In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part II.

Authors:  Jakub Witkowski; Sebastian Polak; Zbigniew Rogulski; Dariusz Pawelec
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.